IN THE NEWS
August 15, 2017:
Avenue Therapeutics Announces Appointment of Joseph Vazzano as Vice President of Finance and Corporate Controller (principal financial and accounting officer)
August 14, 2017:
Fortress Biotech Forms New Subsidiary, Aevitas Therapeutics, Inc., to Develop Novel AAV Gene Therapy Treatments for Complement-Mediated Diseases
August 14, 2017:
Mustang Bio Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
August 11, 2017:
Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
August 9, 2017:
Fortress Biotech Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
July 21, 2017:
Insight about new treatment
Fox News: Fox & friends interview with Fortress Biotech & Mustang Bio
http://video.foxnews.com/v/5515763992001/?#sp=show-clips
QUICK LINKS
PIPELINE
.gif)
